PHK
AGRX

Point72 Hong Kong’s Agile Therapeutics AGRX Stock Holding History

Point72 Hong Kong’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– -$2K – 2467
2021
Q1 		– Hold
0
– – – 1712
2020
Q4 		– Sell
-2
Closed -$14K – 2128
2020
Q3 		$14K Buy
+2
New +$11.5K ﹤0.01% 944

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's AGRX Position: Q2 2021 in Review

Point72 Hong Kong held its Agile Therapeutics (AGRX) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Point72 Hong Kong first reported a position in AGRX in Q3 2020 and has held it in 1 quarter since. The position peaked at $14K in Q3 2020. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

  • Point72 Hong Kong held 0 shares of Agile Therapeutics worth $0 as of Q2 2021.
  • Point72 Hong Kong left its Agile Therapeutics share count unchanged in Q2 2021.
  • Agile Therapeutics made up ﹤0.01% of Point72 Hong Kong's portfolio in Q2 2021, its #2467 holding.
  • Point72 Hong Kong first reported a position in Agile Therapeutics in Q3 2020 and has held it in 1 quarter since.
  • Point72 Hong Kong's Agile Therapeutics position peaked at $14K in Q3 2020.
  • 64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.